Seikagaku Launches HyLink Viscosupplement for Knee Osteoarthritis

Seikagaku commenced Taiwan launch of HyLink®, an intra-articular single-injection viscosupplement for the treatment of knee osteoarthritis, through TCM Biotech International.

The main ingredient of HyLink is a cross-linked hyaluronate hydrogel made using Seikagaku’s crosslinking technology. Since the highly viscoelastic hyaluronate hydrogel...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us